Gujarat Kidney and Super Speciality Ltd

NSE: GKSL · BSE: 544666 · Healthcare · 30 announcements

Share price: ₹187.12
Market cap: ₹1,475 Cr
Revenue (annual): ₹82.01 Cr
Net profit (annual): ₹15.50 Cr
P/E (TTM): 93.2×Sector 53.1×
Promoter holding: 71.45%+0.00% QoQ
FII holding: 4.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 6 Annual General Meeting 6 Legal & Regulatory 3 Financial Results 3 Other Announcement 2 Merger & Restructuring 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual Report 2 Capacity Expansion 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 17:17 IST BSE

Financial Results

Gujarat Kidney and Super Speciality Q1 FY27 Results: Net Profit ₹5.3 Cr, Down 1.9% YoY

Gujarat Kidney and Super Speciality Ltd reported revenue from operations of ₹34.3 Cr (+124.2% YoY) and net profit of ₹5.3 Cr (-1.9% YoY) for Q1 FY27.

Key figure: Net profit ₹5.3 Cr · -1.9% YoY

Open full results → Read the filing ↗

28 May 2026 22:44 IST BSE

Financial Results

Gujarat Kidney and Super Speciality Q4 FY26 Results: Net Profit ₹4.8 Cr, Up 220.0% YoY

Gujarat Kidney and Super Speciality Ltd reported revenue from operations of ₹30.6 Cr (+212.2% YoY) and net profit of ₹4.8 Cr (+220.0% YoY) for Q4 FY26.

Key figure: Net profit ₹4.8 Cr · +220.0% YoY

Open full results → Read the filing ↗

28 May 2026 22:43 IST BSE

Financial Results

Gujarat Kidney and Super Speciality Financial Results

Gujarat Kidney and Super Speciality Ltd reported FY26 consolidated revenue of ₹82.89 Crore. Audited financial results were approved at the May 28, 2026 board meeting.

Read the filing ↗